Moreover, expression levels of PDPN were significantly correlated with increasing glioma grade, whereas TMEM100 showed the opposite pattern (Fig. 5b), suggesting that both of these markers are associated with prognosis, even when low-grade glioma samples were included. This evidence concerns the gene PDPN and central nervous system cancer.